BROOKSNSEBrooks Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Fri, 11 Jul · 13:24 IST

Please find enclosed copy of the certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

BROOKS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Brooks Laboratories Limited has submitted to BSE and NSE a certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, under SEBI's Regulation 74(5) for the quarter ended 30th June 2025. The certificate confirms that any securities received from depository participants for dematerialisation during the quarter were duly processed, confirmed, and reflected in the register of members. A key note from the RTA states that no demat or remat requests were received from shareholders during the quarter, indicating minimal share transfer activity. This is a routine compliance filing, signed by the Company Secretary on 11th July 2025.

Likely market impact

This is a standard regulatory compliance submission with no material impact on the stock price or shareholders. It simply confirms that the company's share transfer machinery is in order, with no notable share movement activity in the quarter.